9HHM | pdb_00009hhm

Crystal structure of phosphatidyl inositol 4-kinase II beta in complex with HH5129


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free: 
    0.240 (Depositor), 0.240 (DCC) 
  • R-Value Work: 
    0.216 (Depositor), 0.216 (DCC) 
  • R-Value Observed: 
    0.217 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9HHM

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Compounds mimicking the Michaelis-Menten transition state of the phosphatidylinositol 4-kinase.

Hrebabecky, H.Klima, M.Dejmek, M.Krupa, P.Fernandez, M.R.Davidova, E.Benysek, J.Martinez-Seara, H.Rozycki, B.Boura, E.Nencka, R.

(2026) Bioorg Med Chem 139: 118666-118666

  • DOI: https://doi.org/10.1016/j.bmc.2026.118666
  • Primary Citation Related Structures: 
    9HHM

  • PubMed Abstract: 

    Phosphatidylinositol 4-kinases (PI4Ks) are crucial enzymes in lipid signaling responsible for generating phosphatidylinositol-4-phosphate (PI4P). Although the ATP-binding site of PI4Ks has been extensively studied, the structural characterization of their natural substrate, phosphatidylinositol (PI), bound to the enzyme remains elusive. In this study, we synthesized novel non-hydrolyzable Michaelis-Menten transition state mimetics in which the ADP molecule is covalently linked to inositol-4-phosphate or simple phosphatidylinositol-4-phosphate via a methylene or ethylene bridge. During our synthesis efforts, we successfully addressed the significantly limited reactivity at position 4 of inositols by utilizing P(III) phosphorus reagents, which proved crucial for the synthesis of these mimetics. For the simplest ADP-C-4PI analogue, we obtained a crystal structure of PI4K2B, which can be used to understand how these phospholipids are phosphorylated on membrane surfaces.


  • Organizational Affiliation
    • Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i, Flemingovo náměstí 542/2, 166 10 Prague, Czech Republic.

Macromolecule Content 

  • Total Structure Weight: 120.56 kDa 
  • Atom Count: 7,458 
  • Modeled Residue Count: 897 
  • Deposited Residue Count: 1,034 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Phosphatidylinositol 4-kinase type 2-beta,Endolysin
A, B
517Homo sapiensTequatrovirus T4Mutation(s): 0 
Gene Names: PI4K2B
EC: 2.7.1.67 (PDB Primary Data), 3.2.1.17 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for P00720 (Enterobacteria phage T4)
Explore P00720 
Go to UniProtKB:  P00720
Find proteins for Q8TCG2 (Homo sapiens)
Explore Q8TCG2 
Go to UniProtKB:  Q8TCG2
PHAROS:  Q8TCG2
GTEx:  ENSG00000038210 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP00720Q8TCG2
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1IVA
(Subject of Investigation/LOI)

Query on A1IVA



Download:Ideal Coordinates CCD File
C [auth A],
D [auth B]
(1~{S},2~{S},4~{S},5~{R})-6-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-bis(oxidanylidene)-$l^{6}-phosphanyl]oxy-bis(oxidanylidene)-$l^{6}-phosphanyl]methyl-bis(oxidanylidene)-$l^{6}-phosphanyl]oxycyclohexane-1,2,3,4,5-pentol
C17 H25 N5 O17 P3
SXKKMVQPOLWBJB-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.25 Å
  • R-Value Free:  0.240 (Depositor), 0.240 (DCC) 
  • R-Value Work:  0.216 (Depositor), 0.216 (DCC) 
  • R-Value Observed: 0.217 (Depositor) 
Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 105.24α = 90
b = 105.24β = 90
c = 211.64γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
XDSdata scaling
PHASERphasing
Cootmodel building
PHENIXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2025-12-03
    Type: Initial release
  • Version 1.1: 2026-05-20
    Changes: Database references